Skip to content
Screener

Artivion AORT Q2 2026 earnings

Reported August 6, 2026 · After market close

Revenue$125.8MBeat by $5.8M
EPS-$0.28Miss by $0.28
Revenue estimate$120.0M
EPS estimate$0.00
“In the second quarter of 2026, we delivered 9% constant currency revenue growth and 7% adjusted EBITDA growth, reflecting continued execution of our strategy to drive long-term, profitable growth through an expanding and clinically differentiated product portfolio. Revenue growth was once again driven primarily by On-X and stent grafts, including AMDS, with On-X growing 18% and stent grafts growing 12% on a constant currency basis, both compared to the second quarter of 2025.”
Pat Mackin

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$120.9M
EPS estimate$0.11

Financials

Q2 2026

Income statement

See full
Revenue$125.8M+11.3%
Gross profit$80.5M+10.1%
Operating income-$8.4M-200%
Net income-$13.5M-1,104%
EPS (diluted)-$0.28-1,033%

Balance sheet

See full
Cash & equivalents$77.3M+44.6%
Total debt$408.0M+54.7%
Total equity$445.6M+6.1%
Total assets$1.1B+27.9%

Cash flow

See full
Operating cash flow-$1.3M-108%
CapEx$10.7M+227%
Free cash flow-$12.0M—

Valuation & ratios

Valuation

as of 09/17/26
See full
Market cap$1.24B-35.3%
Enterprise value$1.57B-26.0%
P/S2.6×-2.1×

Profitability

See full
Gross margin64.4%+0.4pp
Operating margin4.4%0.0pp
Net margin-0.7%-0.3pp

Returns & leverage

See full
Return on equity-0.7%-0.3pp
Debt / equity0.9×+0.3×
Current ratio3.5×-1.3×

Segments

By segment

See full
North America$62.3M+8.3%
EMEA$44.5M+15.1%
APAC$12.2M+9.3%
LATAM$6.7M+20.7%

By product

See full
Aortic stent grafts$46.4M+16.5%
On-X$30.5M+19.3%
Surgical sealants$19.3M0.0%
Other$3.7M+34.8%

FAQ

When did Artivion report Q2 2026 earnings?
Artivion (AORT) reported Q2 2026 earnings on August 6, 2026 after market close.
What were Artivion's Q2 2026 revenue and EPS?
Artivion reported revenue of $125.8M and eps of $-0.28 for Q2 2026.
Did Artivion beat estimates in Q2 2026?
Revenue beat the consensus estimate of $120.0M by $5.8M. EPS missed the consensus estimate of $0.00 by $0.28.
How did Artivion's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 11.3% from $113.0M a year earlier.
Where can I find Artivion's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-054294) and the 10-Q periodic report (0001628280-26-054746) directly on SEC EDGAR. The filing index links above go to sec.gov.